The interaction of antibiotics, bacteria and the bacterial L-phase in vivo.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002701:Chloramphenicol / Q000494:pharmacology; D002751:Chlortetracycline / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D013293:Enterococcus faecalis / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D005620:Freund's Adjuvant / Q000009:adverse effects; D007740:L Forms / Q000187:drug effects / Q000472:pathogenicity; D051379:Mice; D009174:Mycoplasma / Q000472:pathogenicity; D010118:Oxytetracycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010532:Peritoneal Diseases / Q000209:etiology; D011113:Polymyxins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D004917:Erythromycin; D002701:Chloramphenicol; D005620:Freund's Adjuvant; D013752:Tetracycline; D010400:Penicillin G; D004096:Dihydrostreptomycin Sulfate; D002751:Chlortetracycline; D010118:Oxytetracycline